PIA
ABBV icon

Petredis Investment Advisors’s AbbVie ABBV Stock Holding History

Petredis Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.38M Buy
21,382
+18
+0.1% +$3.87K 0.36% 55
2026
Q1 		$4.65M Sell
21,364
-213
-1% -$47.2K 0.38% 58
2025
Q4 		$4.93M Sell
21,577
-266
-1% -$60.6K 0.39% 54
2025
Q3 		$5.06M Sell
21,843
-256
-1% -$52.1K 0.41% 52
2025
Q2 		$4.1M Buy
22,099
+234
+1% +$43.5K 0.36% 59
2025
Q1 		$4.58M Buy
21,865
+333
+2% +$64.7K 0.48% 46
2024
Q4 		$3.83M Sell
21,532
-446
-2% -$82K 0.4% 52
2024
Q3 		$4.34M Buy
21,978
+26
+0.1% +$4.85K 0.46% 47
2024
Q2 		$3.77M Sell
21,952
-22
-0.1% -$3.64K 0.42% 53
2024
Q1 		$4M Buy
21,974
+568
+3% +$97.9K 0.48% 50
2023
Q4 		$3.32M Sell
21,406
-674
-3% -$98.3K 0.44% 56
2023
Q3 		$3.29M Buy
22,080
+57
+0.3% +$8.37K 0.47% 54
2023
Q2 		$2.97M Sell
22,023
-38
-0.2% -$5.57K 0.41% 57
2023
Q1 		$3.52M Buy
22,061
+246
+1% +$37.6K 0.55% 51
2022
Q4 		$3.53M Buy
+21,815
New +$3.34M 0.64% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Petredis Investment Advisors's ABBV Position: Q2 2026 in Review

Petredis Investment Advisors increased its AbbVie (ABBV) stake by 0.08% in Q2 2026, buying an estimated $3.87K and bringing the position to 21,382 shares worth $5.38M. The position accounts for 0.36% of the portfolio, ranked #55.

Petredis Investment Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Petredis Investment Advisors held 21,382 shares of AbbVie worth $5.38M as of Q2 2026.
  • Petredis Investment Advisors bought 18 AbbVie shares in Q2 2026, an estimated $3.87K.
  • AbbVie made up 0.36% of Petredis Investment Advisors's portfolio in Q2 2026, its #55 holding.
  • Petredis Investment Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Petredis Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.